Development of an Evidence-Based List of Noncytotoxic Vesicant Medications and Solutions

@article{Gorski2017DevelopmentOA,
  title={Development of an Evidence-Based List of Noncytotoxic Vesicant Medications and Solutions},
  author={Lisa A. Gorski and Marc Stranz and Lynda S. Cook and James M Joseph and Kathy Kokotis and Pam Sabatino-Holmes and Lori Van Gosen},
  journal={Journal of Infusion Nursing},
  year={2017},
  volume={40},
  pages={26–40}
}
Infiltration of a vesicant medication, defined as extravasation, may result in significant patient injuries. The first step in preventing extravasation is the identification and recognition of vesicant medications and solutions. Because there is no list of noncytotoxic vesicants as established by a professional organization, the Infusion Nurses Society, as the global authority in infusion nursing, identified the need to address this gap. A task force was formed for the purpose of creating an… 
Recommendations for Management of Noncytotoxic Vesicant Extravasations
  • J. Ong, R. Van Gerpen
  • Medicine
    Journal of infusion nursing : the official publication of the Infusion Nurses Society
  • 2020
TLDR
A literature review was performed to identify noncytotoxic vesicants and to create evidence and consensus-based recommendations to prepare clinicians to treat extravasation of noncyTotoxic Vesicant with antidotes and thermal compresses.
Classification of non-antineoplastic intravenously administered drugs according to their toxicity risk: the path towards safe drug administration
TLDR
The classification of intravenously administered drugs according to their risk profile is useful to ensure their safe use, as it can be used to implement the necessary safety measures to prevent adverse events.
Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety
TLDR
The aim of this study was to standardize the dilutions of intravenous drugs most commonly used in hospitalized adult patients and to characterize their pH, osmolarity and cytotoxic nature to better guide the selection of the most appropriate vascular access.
2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy.
  • A. Norris, N. Shrestha, C. Umscheid
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2019
TLDR
This guideline is intended to provide insight for healthcare professionals who prescribe and oversee the provision of OPAT and considers various patient features, infusion catheter issues, monitoring questions, and antimicrobial stewardship concerns.
2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy.
  • A. Norris, N. Shrestha, C. Umscheid
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2019
TLDR
This guideline is intended to provide insight for healthcare professionals who prescribe and oversee the provision of OPAT and considers various patient features, infusion catheter issues, monitoring questions, and antimicrobial stewardship concerns.
Antimicrobial Agents and Catheter Complications in Outpatient Parenteral Antimicrobial Therapy
TLDR
This work investigates associations between antimicrobial agent(s) and catheter complications and investigates whether patients requiring home‐based outpatient parenteral antimicrobial therapy (OPAT) should receive peripheralCatheters versus central venous catheters.
Evidence-Based Strategies and Recommendations for Preservation of Central Venous Access in Children.
TLDR
This state-of-the-art review identifies known failure points in the current systems of venous care, details the elements of an individualized plan of care, and emphasizes a patient-centered, multidisciplinary, collaborative, and evidence-based approach to care in these vulnerable populations.
Inflammatory, Mechanical and Infectious Complications Associated with Peripheral Intravenous Catheters in Dogs and Cats: A Risk Factor Analysis
TLDR
PIVC-associated complications were frequently observed, and the high rate of positive culture for PIVCs, together with the presence of multi-resistant isolates, is a cause of concern in a hospital setting.
Investigation of the role of infusate properties related to midline catheter failure in an ovine model
  • M. Ryder, R. Gunther, Charles J Sylvia
  • Medicine
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2020
TLDR
Administration of infusates of varied pH, osmolarity, and cytotoxicity via midline catheter resulted in severe vascular injury and premature catheter failure; therefore, the tested infUSates should not be infused via mid line catheters.
Peripheral Intravenous Administration of High-Risk Infusions in Critical Care: A Risk-Benefit Analysis.
TLDR
Recent studies that challenge the need for central catheter placement for vasopressor therapy, current knowledge of peripheral intravenous catheter-related adverse events, and evidence-based standards of care for short peripheral intravenously catheter insertion and maintenance are reviewed.
...
1
2
3
...